Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene Names Schechter as New President and CEO

Premium

WOBURN, Mass.--The bioinformatics company AlphaGene has named Alan Schechter as its new president and CEO, replacing George Scheele, who will remain as AlphaGene's chairman of the board and chief scientific officer.

Schechter was previously president and CEO of Applied Carotenoid Sciences Inc., a biopharmaceutical device R&D company. AlphaGene is focused on developing technologies for gene and protein discovery to accelerate drug development.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.